On December 8, 2025, Broadwood Partners L P announced that independent proxy advisory firm has reaffirmed its recommendation to shareholders of STAAR Surgical Company, vote against the proposed acquisition of the Company by Alcon Inc, and stating that although the merger agreement has been amended to include a go-shop provision and a revised termination fee, ultimately, it recommend against the merger due to the proposed valuation and the belief that Company?s standalone value is greater than what would be received in the proposed transaction. In addition, Broadwood Partners stating that it has called for new directors, but the Board refused to adjust its composition to provide shareholders any basis for confidence in this new go-shop process, instead, this latest process was, as Egan-Jones notes, overseen by the same directors, executives, bankers, and lawyers who designed and executed an inappropriate and flawed sale process in the first place. Further, Broadwood Partners stated that it is working to call a Special Meeting to remove from the Board the 3 directors Elizabeth Yeu, Stephen Farrell, and Arthur Butcher, and continued to urge the Company shareholders to vote against the proposed acquisition of the Company.